Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV-6 trial showed. After receiving ...
The effectiveness of repurposed medications for treating COVID-19 remains a critical area of investigation. A new analysis found that higher-dose fluvoxamine (Luvox), an antidepressant with ...
22% more likely to have a pulmonary issue. Dr. Ishwara Sankara, a neurointensivist with Texas Health Fort Worth, told KERA’s Sam Baker this may stem from inflammation. COVID-19 showed us the ...
About The Study: In this randomized clinical trial of outpatients with mild to moderate COVID-19, treatment with montelukast did not reduce duration of COVID-19 symptoms. These findings do not support ...
Hosted on MSN
COVID-19 Cases Rise: 5 Tried-and-tested Home Remedies That Can Help Treat Mild Coronavirus Symptoms
There has been a huge surge in cases of COVID-19 across Southeast Asia, especially in densely populated cities like Singapore, Hong Kong, and Bangkok. In India too, states like Kerala, Maharashtra, ...
SAN DIEGO, Calif. — People suffering life-derailing symptoms after recovering from COVID-19 are getting more access to care. "Can be like as little as, you know, vacuuming. And you're on the couch for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results